World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
71
Citations
18098
World Ranking
6645
National Ranking
3090

Samuel D. Rabkin publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Samuel D. Rabkin sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 227 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Samuel D. Rabkin D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Samuel D. Rabkin sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 71 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Samuel D. Rabkin is affiliated with Harvard University in the United States and has contributed extensively to research in biochemistry, genetics, molecular biology, and medicine. Their work focuses significantly on virus-based gene therapy, herpesvirus infections and treatments, CAR-T cell therapy, cancer research, and glioma diagnosis and treatment. The scientist's publications also touch on viral infectious diseases and gene expression in insects, as well as viral gastroenteritis research and epidemiology.

The main fields of study represented in their research include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Subfields within their research activity span:

  • Genetics
  • Epidemiology
  • Oncology
  • Molecular Biology
  • Biotechnology

The primary topics of their work comprise:

  • Virus-based gene therapy research
  • Herpesvirus Infections and Treatments
  • CAR-T cell therapy research
  • Cancer Research and Treatments
  • Viral Infectious Diseases and Gene Expression in Insects
  • Glioma Diagnosis and Treatment
  • Viral gastroenteritis research and epidemiology

Among frequent coauthors collaborating with Samuel D. Rabkin are Hiroaki Wakimoto, Robert L. Martuza, Dipongkor Saha, Howard L. Kaufman, and Judit Sánchez Gil.

Samuel D. Rabkin's work appears frequently in several scientific journals. The most common publication venues include:

  • Neuro-Oncology
  • Journal for ImmunoTherapy of Cancer
  • Journal of Visualized Experiments
  • Clinical Cancer Research
  • Expert Opinion on Drug Discovery

Selected recent papers authored or coauthored by Samuel D. Rabkin include:

  • Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma, 2020, Clinical Cancer Research
  • Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma, 2020, Journal for ImmunoTherapy of Cancer
  • Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma, 2020, Acta Neuropathologica Communications
  • The discovery and development of oncolytic viruses: are they the future of cancer immunotherapy?, 2020, Expert Opinion on Drug Discovery
  • Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival, 2024, Journal for ImmunoTherapy of Cancer

Best Publications

  • Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.

    J M Markert;M D Medlock;S D Rabkin;G Y Gillespie

  • Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas

    Toshihiro Mineta;Samuel D. Rabkin;Takahito Yazaki;William D. Hunter

  • Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells

    Mario Luca Suva;Mario Luca Suva;Mario Luca Suva;Esther Rheinbay;Esther Rheinbay;Esther Rheinbay;Shawn M. Gillespie;Shawn M. Gillespie;Shawn M. Gillespie;Anoop Premswaroop Patel;Anoop Premswaroop Patel

  • Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.

    Tomoki Todo;Robert L. Martuza;Samuel D. Rabkin;Paul A. Johnson

  • Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade

    Dipongkor Saha;Robert L. Martuza;Samuel D. Rabkin

  • Oncolytic Viruses and Their Application to Cancer Immunotherapy

    Chiocca Ea;Rabkin Sd

  • Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors

    Hiroaki Wakimoto;Santosh Kesari;Christopher J. Farrell;William T. Curry

  • Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity.

    Masahiro Toda;Samuel D. Rabkin;Hidefumi Kojima;Robert L. Martuza

  • Oncolytic herpes simplex virus vectors for cancer virotherapy

    Susan Varghese;Samuel D Rabkin

  • Treatment of Malignant Gliomas Using Ganciclovir-hypersensitive, Ribonucleotide Reductase-deficient Herpes Simplex Viral Mutant'

    Toshihiro Mineta;Samuel D. Rabkin;Robert L. Martuza

  • An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma

    Esther Rheinbay;Mario L. Suvà;Mario L. Suvà;Mario L. Suvà;Shawn M. Gillespie;Shawn M. Gillespie;Shawn M. Gillespie;Hiroaki Wakimoto

  • Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells

    Hiroaki Wakimoto;Gayatry Mohapatra;Ryuichi Kanai;William T. Curry

  • Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation of Intracerebral Injection in Nonhuman Primates

    William D. Hunter;Robert L. Martuza;Frank Feigenbaum;Tomoki Todo

  • Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus.

    Tomoki Todo;Samuel D. Rabkin;Periasamy Sundaresan;Aiguo Wu

  • In Situ Cancer Vaccination: An IL-12 Defective Vector/Replication-Competent Herpes Simplex Virus Combination Induces Local and Systemic Antitumor Activity

    Masahiro Toda;Robert L. Martuza;Hidefumi Kojima;Samuel D. Rabkin

  • Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector.

    M G Kaplitt;A D Kwong;S P Kleopoulos;C V Mobbs

  • Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model.

    Tooba A. Cheema;Hiroaki Wakimoto;Peter E. Fecci;Jianfang Ning

  • Treatment of Human Malignant Meningiomas by G207, a Replication-competent Multimutated Herpes Simplex Virus 1

    Takahito Yazaki;Herbert J. Manz;Samuel D. Rabkin;Robert L. Martuza

  • Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1

    Masahiro Toda;Samuel D. Rabkin;Robert L. Martuza

  • Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells

    Mario L. Suvà;Esther Rheinbay;Shawn M. Gillespie;Anoop P. Patel

Frequent Co-Authors

Robert L. Martuza
Robert L. Martuza Harvard Medical School
Tomoki Todo
Tomoki Todo University of Tokyo
Donald W. Pfaff
Donald W. Pfaff Rockefeller University
Bradley E. Bernstein
Bradley E. Bernstein Broad Institute
Khalid Shah
Khalid Shah Brigham and Women's Hospital
David N. Louis
David N. Louis Harvard University
Luc Jasmin
Luc Jasmin University of California, San Francisco
Yechiel Becker
Yechiel Becker Hebrew University of Jerusalem
Miguel Rivera
Miguel Rivera Harvard University
Aviv Regev
Aviv Regev Genentech

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Samuel D. Rabkin

Trending Scientists

Recently Published Articles